NASA is preparing to send a suite of health-focused experiments to the International Space Station aboard SpaceX's 35th Commercial Resupply Services mission, launching from Cape Canaveral Space Force Station in Florida. The four investigations, overseen by the agency's Biological and Physical Sciences division, are designed to advance research that benefits life on Earth while supporting astronaut health on long-duration missions.
The payload includes miniature, lab-grown models of the human brain that will spend five weeks in orbit. Researchers plan to compare the tissue models that traveled to space with identical ones kept on the ground, looking for changes at the cellular level. The goal is to understand how even a short spaceflight affects the brain, which could help scientists anticipate and counter the neurological risks astronauts may face on future missions to the Moon and beyond.
A second experiment will examine whether crop diseases develop faster and more severely in microgravity. The study compares molecular and structural changes in plants infected with a disease-causing fungus, pitting Earth-grown specimens against those cultivated on the station. The findings could inform plant breeding on Earth to produce more disease-resistant crops and help reduce yield losses in the space agriculture systems that will be needed as human missions extend farther from the planet.
Space crops are not only a source of nutrition and dietary variety for astronauts; they also provide psychological benefits during long stays in orbit. Plants absorb carbon dioxide, produce oxygen and recycle water, functions that become increasingly critical as crews venture deeper into space where resupply is difficult.
The mission also carries the first test of a compact microplate reader that arrived at the station earlier this year. The Commercially Enabled Rapid Space Science initiative will evaluate the device's ability to detect and measure biomarkers such as antibodies, antigens and proteins. If successful, the reader would allow scientists to analyze samples aboard the station and get results quickly, rather than waiting for samples to return to Earth. That capability could support timely detection of infections and other health problems in astronauts and expand research in remote exploration locations.
Finally, a precision health investigation returns for its fourth and final planned stay aboard the orbiting laboratory to study how antibiotic-resistant bacteria survive and evolve in microgravity. Astronauts will repeatedly sample surfaces throughout the station to monitor for drug-resistant organisms. The work could help develop ways to protect crews against bacterial infections during long-duration missions, and on Earth it may offer insight into how superbugs emerge from the overuse of antibiotics.
Together, the four investigations reflect NASA's broader push to use the space station as a testbed for biological and physical research. By studying the brain, crops, rapid diagnostics and microbial resistance in orbit, the agency hopes to address both the practical needs of future exploration and health challenges that affect people on the ground.
11
